BSECompany Update6d ago · 9 Oct 2026, 11:41 am
Post Quarterly Financial Result Conference call with investors / analyst
Torrent Pharmaceuticals Ltd · 500420
✦ AI SummaryResults
Torrent Pharmaceuticals Ltd has scheduled a teleconference with investors/analysts on 23rd October, 2026 to discuss the financial performance of the company for the quarter and half year ended 30th September, 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Torrent Pharmaceuticals Ltd - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Attachments (1)
📄pdf
Download →
aa1cd9f9-082c-4743-bdd0-cbeb855ec58f.pdf
View document text
09th October, 2026
The Dy. General Manager (Listing Dept.) The Manager – Listing Dept.,
BSE Limited., National Stock Exchange of India Ltd.,
Corporate Relationship Dept., Exchange Plaza, 5th Floor,
1st Floor, New Trading Ring, Plot No. C/1, G. Block,
P. J. Towers, Dalal Street, Fort, Bandra - Kurla Complex, Bandra (E),
Mumbai - 400 001 Mumbai – 400 051
(BSE Scrip Code: 500420) (NSE Scrip Code: TORNTPHARM)
Dear Sir,
Sub.: Post Quarterly Financial Result Conference call with investors / analyst
We hereby inform that the Company has scheduled a teleconference with Investors / Analysts on
23rd October, 2026 at 05:30 P.M. to discuss the financial performance of the Company for the
quarter and half year ended 30th September, 2026.
Conference call – Dial in information:
Universal dial-in +91 22 6280 1439
+91 22 7115 8803
India National Toll Free 1 800 120 1221
International Toll Free
Argentina 0080014243444
Australia 0080014243444
Belgium 0080014243444
Canada 01180014243444
China 4008428405
France 0800914745
Germany 0080014243444
Hong Kong 800964448
Italy 0080014243444
Japan 00531161110
Netherlands 08000229808
Poland 008001124248
Singapore 8001012045
South Korea 00180014243444
Email – investorservices@torrentpharma.com
Sweden 0080014243444
Thailand 00180014243444
UK 08081011573
USA 18667462133
Diamond Pass Registration Link
https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=0173484
&linkSecurityString=1846085f4
The above is for your information and record.
Thanking you,
Yours sincerely,
For TORRENT PHARMACEUTICALS LIMITED
CHINTAN M. TRIVEDI
COMPANY SECRETARY
Email – investorservices@torrentpharma.com